ESC 365 - Safety of non-vitamin K antagonist oral anticoagulants - Considerations for management of atrial fibrillation patients .

ESC Premium Access

Safety of non-vitamin K antagonist oral anticoagulants - Considerations for management of atrial fibrillation patients .

Session: Oral anticoagulation in atrial fibrillation - From evidence-based medicine to daily clinical practice

Topic: Treatment

Speaker: Doctor C. Ruff (Boston, US)

Sponsored by Daiichi Sankyo

Event: ESC Congress 2018

Congress Presentation

Add to my library

About the speaker

Doctor Christian Ruff

Brigham and Women's Hospital, Boston (United States of America)

25 presentations

0 follower

5 more presentations in this session

Introduction - Oral anticoagulation in atrial fibrillation - From evidence-based medicine to daily clinical practice.

Speaker: Doctor J. Weitz (Hamilton, CA)

Implication of the new EHRA practical guide for the treatment of atrial fibrillation patients.

Speaker: Professor J. Steffel (Zurich, CH)

Complementing results from randomised trials: the value of international observational studies.

Speaker: Professor P. Kirchhof (Hamburg, DE)

Panel discussion - Oral anticoagulation in atrial fibrillation - From evidence-based medicine to daily clinical practice

Speaker: Doctor J. Weitz (Hamilton, CA)

Summary and close - Oral anticoagulation in atrial fibrillation - From evidence-based medicine to daily clinical practice.

Speaker: Professor P. Kirchhof (Hamburg, DE)

Access the full session

Oral anticoagulation in atrial fibrillation - From evidence-based medicine to daily clinical practice

Speakers: Doctor C. Ruff, Doctor J. Weitz, Professor J. Steffel, Professor P. Kirchhof, Doctor J. Weitz...

About the event

ESC Congress 2018

25 August - 29 August 2018

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources

Explore sponsored resources